ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

GC Biopharma Corp. clinical trials

Also known as Green Cross, GC Pharma.

Part of GC Corp. (Green Cross Holdings), which holds 50.06% as of 2024-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 79 studies whose lead sponsor is GC Biopharma Corp. 7 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 16, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare GC Biopharma with GlaxoSmithKline and BioNTech →

Pipeline: 7 programs

Each counted once: 7 with a study GC Biopharma Corp. leads registered in the last two years.

  • Phase 2
  • Phase 3

The 3 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of GC Biopharma Corp.’s own registered studies; GC Biopharma Corp.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs GC Biopharma Corp.’s studies test, most open studies first — 16 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 6 more

Coming up

5 of GC Biopharma Corp.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 1M
  8. 2J
  9. J
  10. 1A
  11. S
  12. 1O
  13. N

Add all 5 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 79 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now79%Recruiting 5 · Not yet recruiting 1 · Enrolling by invitation 1
  • Under way, not recruiting56%
  • Completed4557%
  • Stopped early34%Terminated 2 · Withdrawn 1
  • Status unknown or other1924%

Phase

  • Phase 334
  • Phase 126
  • Phase 224
  • Phase 44

Where

  • Korea, Republic of58
  • United States9
  • Canada3
  • United Kingdom1
  • Thailand1
  • New Zealand1

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 914
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 426

By the year each study started; 1 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to GC Biopharma Corp.

  • Green Cross Corporation
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    63 studies
  • GC Biopharma Corp
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    16 studies

Focus areas

Conditions GC Biopharma Corp. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 79. Browse all 79 →